Zobrazeno 1 - 10
of 256
pro vyhledávání: '"Oxipurinol"'
Autor:
Peter Hausler, Simon Heckscher, Lukas Wunderlich, Rudolf Bierl, Johannes Fischer, Thomas Hirsch, Christina Pfab
Publikováno v:
Optical Sensors 2019.
The analysis of surface water, groundwater, drinking water as well as sewage is important to get information about the contamination of the water cycle. Currently, these time-consuming investigations require special equipment, like for example hyphen
Autor:
Eric N. van Roon, Lars C. Nijdam, M.K. Reinders, Mart A F J van de Laar, T.L.Th.A. Jansen, Jacobus R. B. J. Brouwers, Kris L. L. Movig
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis, 45(2), 312-317. ELSEVIER SCIENCE BV
Journal of pharmaceutical and biomedical analysis, 45(2), 312-317. Elsevier
Journal of pharmaceutical and biomedical analysis, 45(2), 312-317. Elsevier
Objectives: Allopurinol is a uric acid lowering drug used in the treatment of gout and the prevention of tumor lysis syndrome. Allopurinol and its active metabolite oxipurinol inhibit xanthine oxidase, which forms uric acid from xanthine and hypoxant
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Current Pharmaceutical Design
Xanthine oxidoreductase (XOR), a complex flavoprotein, catalyzes the metabolic reactions leading from hypoxanthine to xanthine and from xanthine to urate, and both reactions take place at the molybdenum cofactor. The enzyme is a target of drugs for t
Publikováno v:
Analogue-Based Drug Discovery III
Publikováno v:
Pharmaceutisch Weekblad. 147(11):41-44
Publikováno v:
European Journal of Clinical Pharmacology. 67:709-713
To determine whether low-dose aspirin and hydrochlorothiazide (HCTZ) affect the renal clearance of oxypurinol and/or urate.Healthy volunteers (n = 8) were treated with allopurinol (600 mg, control), and allopurinol (600 mg) co-administered with singl
Measurement of urinary oxypurinol by high performance liquid chromatography–tandem mass spectrometry
Autor:
Sophie L. Stocker, Jacqueline M. Anderson, Michael E. Franklin, Peter I. Pillans, Andrew J. McLachlan, Paul J. Taylor, Kenneth M. Williams, Richard O. Day
Publikováno v:
Journal of Chromatography B. 878:2363-2368
Oxypurinol is the active metabolite of allopurinol which is used to treat hyperuricaemia associated with gout. Both oxypurinol and allopurinol inhibit xanthine oxidase which forms uric acid from xanthine and hypoxanthine. Plasma oxypurinol concentrat
Publikováno v:
European Journal of Pharmacology. 621:71-77
Previously, we showed that oral allopurinol increased survival in mice with post-ischemic cardiomyopathy and attributed this outcome to an improvement of excitation-contraction coupling that boosted contractility. In this study, we tested the sustain
Publikováno v:
Nucleosides, Nucleotides and Nucleic Acids. 27:888-893
Inhibitors of xanthine oxidoreductase block conversion of xanthine to uric acid and are therefore potentially useful for treatment of hyperuricemia or gout. We determined the crystal structure of reduced bovine milk xanthine oxidoreductase complexed